eilatine has been researched along with Leukemia, Myelogenous, Chronic, BCR-ABL Positive in 2 studies
*Leukemia, Myelogenous, Chronic, BCR-ABL Positive: Clonal hematopoetic disorder caused by an acquired genetic defect in PLURIPOTENT STEM CELLS. It starts in MYELOID CELLS of the bone marrow, invades the blood and then other organs. The condition progresses from a stable, more indolent, chronic phase (LEUKEMIA, MYELOID, CHRONIC PHASE) lasting up to 7 years, to an advanced phase composed of an accelerated phase (LEUKEMIA, MYELOID, ACCELERATED PHASE) and BLAST CRISIS. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiel, A; Einat, M; Fabian, I; Kashman, Y; Lishner, M; Markel, D; Nagler, A; Rudi, A; Yarkorli, S | 1 |
| Amiel, A; Einat, M; Fabian, I; Fejgin, MD; Kashman, Y; Nagler, A; Rudi, A | 1 |
2 other study(ies) available for eilatine and Leukemia, Myelogenous, Chronic, BCR-ABL Positive
| Article | Year |
|---|---|
Eilatin: a novel marine alkaloid inhibits in vitro proliferation of progenitor cells in chronic myeloid leukemia patients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Agents; Bone Marrow; Cell Division; Cell Survival; Child; Child, Preschool; Cytarabine; Female; Hematopoietic Stem Cells; Humans; In Situ Hybridization, Fluorescence; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Phenanthrolines; Tumor Cells, Cultured | 1995 |
Synergistic effects of interleukin-11 with other growth factors on the expansion of hematopoietic progenitors from normal individuals and chronic myeloid leukemia patients resistant to treatment with cytosine arabinoside or eilatin.
Topics: Animals; Antineoplastic Agents; CHO Cells; Cricetinae; Cytarabine; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cells; Humans; Interleukin-11; Interleukin-3; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phenanthrolines; Stem Cell Factor; Tumor Stem Cell Assay | 1996 |